These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24530750)

  • 1. CTLA-4 polymorphisms and susceptibility to inflammatory bowel disease: a meta-analysis.
    Lee YH; Kim JH; Seo YH; Choi SJ; Ji JD; Song GG
    Hum Immunol; 2014 May; 75(5):414-21. PubMed ID: 24530750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polymorphisms K469E and G261R of intercellular adhesion molecule-1 and susceptibility to inflammatory bowel disease: a meta-analysis.
    Song GG; Lee YH
    Immunol Invest; 2015; 44(4):361-72. PubMed ID: 25942347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4 and TNF-α promoter-308 A/G polymorphisms and ANCA-associated vasculitis susceptibility: a meta-analysis.
    Lee YH; Choi SJ; Ji JD; Song GG
    Mol Biol Rep; 2012 Jan; 39(1):319-26. PubMed ID: 21553055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis.
    Gyu Song G; Ho Lee Y
    Immunol Invest; 2013; 42(5):409-22. PubMed ID: 23802171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between NRAMP1 Polymorphisms and Susceptibility to Ulcerative Colitis/Crohn's Disease: A Meta-Analysis.
    Sun M; Zhang L; Shi S
    Immunol Invest; 2016; 45(3):255-70. PubMed ID: 27019053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms.
    Repnik K; Potocnik U
    DNA Cell Biol; 2010 Oct; 29(10):603-10. PubMed ID: 20491567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the association between CTLA-4 +49 A/G, -318 C/T, and IL-1 polymorphisms and susceptibility to cervical cancer.
    Lee YH; Song GG
    Neoplasma; 2014; 61(4):481-90. PubMed ID: 24712845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.
    Zhao JJ; Wang D; Yao H; Sun DW; Li HY
    World J Gastroenterol; 2015 Sep; 21(34):10025-40. PubMed ID: 26379408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between CTLA-4 polymorphisms and susceptibility to Celiac disease: a meta-analysis.
    Song GG; Kim JH; Kim YH; Lee YH
    Hum Immunol; 2013 Sep; 74(9):1214-8. PubMed ID: 23770251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis.
    Zou L; Wang L; Gong X; Zhao H; Jiang A; Zheng S
    Autoimmunity; 2014 Feb; 47(1):27-39. PubMed ID: 24128120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis.
    Song GG; Kim JH; Lee YH
    Mol Biol Rep; 2013 Apr; 40(4):2985-93. PubMed ID: 23264102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CTLA-4 variants with susceptibility to inflammatory bowel disease: a meta-analysis.
    Zhang M; Ni J; Xu WD; Wen PF; Qiu LJ; Wang XS; Pan HF; Ye DQ
    Hum Immunol; 2014 Mar; 75(3):227-33. PubMed ID: 24374044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between the cytotoxic T lymphocyte antigen-4 gene microsatellite polymorphism and inflammatory bowel diseases in the Chinese].
    Jiang Y; Xia B
    Zhonghua Nei Ke Za Zhi; 2004 Mar; 43(3):191-4. PubMed ID: 15059373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytotoxic T lymphocyte antigen-4 promoter gene polymorphism is significantly associated with ulcerative colitis].
    Zhou F; Xia B; Guo QS; Wang Q; Li L; Jiang L; Cheng H
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):478-81. PubMed ID: 16831326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
    Senhaji N; Serbati N; Diakité B; Arazzakou S; Hamzi K; Badre W; Nadifi S
    Gene; 2013 May; 521(1):45-9. PubMed ID: 23542077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis.
    Lee YH; Song GG
    Mol Biol Rep; 2012 Sep; 39(9):9041-5. PubMed ID: 22722994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis.
    Huang XL; Xu DH; Wang GP; Zhang S; Yu CG
    World J Gastroenterol; 2015 May; 21(19):6052-9. PubMed ID: 26019472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 CT60 (rs3087243) polymorphism and autoimmune thyroid diseases susceptibility: a comprehensive meta-analysis.
    Ni J; Qiu LJ; Zhang M; Wen PF; Ye XR; Liang Y; Pan HF; Ye DQ
    Endocr Res; 2014; 39(4):180-8. PubMed ID: 24697361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.